New Key Statistics Module, Z-Score and F-Score
NAS:VERV Key Ratios
| Market Cap $ M | 443.34 |
| Enterprise Value $ M | -89.36 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | -- |
| Price/Book | 0.76 |
| Price/Sales | 24.56 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 16.00 |
| EPS (TTM) $ | -2.87 |
| Beneish M-Score | 0.65 |
| 10-y EBITDA Growth Rate % | -- |
| 5-y EBITDA Growth Rate % | -- |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | 0.40 |
| EV-to-EBITDA | 0.41 |
| PEG | -- |
| Shares Outstanding M | 83.97 |
| Net Margin (%) | -1,226.43 |
| Operating Margin % | -1,381.45 |
| Pre-tax Margin (%) | -1,224.05 |
| Quick Ratio | 19.82 |
| Current Ratio | 19.82 |
| ROA % (ttm) | -29.63 |
| ROE % (ttm) | -37.60 |
| ROIC % (ttm) | -167.08 |
| Dividend Yield % | -- |
| Altman Z-Score | 0.75 |
VERV Number of Guru Trades
VERV Volume of Guru Trades
Gurus Latest Trades with NAS:VERV
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:VERV is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Verve Therapeutics Inc Insider Transactions
No Available Data
News about NAS:VERV
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers